APA

Hao M., Franqui-Machin R., Xu H., Shaughnessy J., Barlogie B., Roodman D., Quelle D. E., Janz S., Tomasson M. H., Sanderson R. D., Qiu L., Frech I., Tricot G. & Zhan F. (20180612). NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. : Leukemia.

Chicago

Hao M, Franqui-Machin R, Xu H, Shaughnessy J, Barlogie B, Roodman D, Quelle D E, Janz S, Tomasson M H, Sanderson R D, Qiu L, Frech I, Tricot G and Zhan F. 20180612. NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. : Leukemia.

Harvard

Hao M., Franqui-Machin R., Xu H., Shaughnessy J., Barlogie B., Roodman D., Quelle D. E., Janz S., Tomasson M. H., Sanderson R. D., Qiu L., Frech I., Tricot G. and Zhan F. (20180612). NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. : Leukemia.

MLA

Hao M, Franqui-Machin R, Xu H, Shaughnessy J, Barlogie B, Roodman D, Quelle D E, Janz S, Tomasson M H, Sanderson R D, Qiu L, Frech I, Tricot G and Zhan F. NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. : Leukemia. 20180612.